These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7589768)

  • 1. Time-course of changes in the plasma-membrane lipid bilayer and cellular ultrastructure induced by tumour necrosis factor-alpha in K 562 and Daudi cells.
    Marutaka M; Iwagaki H; Mizukawa K; Tanaka N; Orita K
    J Int Med Res; 1995; 23(4):254-63. PubMed ID: 7589768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell membrane fluidity in K562 cells and its relation to receptor expression.
    Iwagaki H; Marutaka M; Nezu M; Suguri T; Tanaka N; Orita K
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):141-9. PubMed ID: 7994558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of TNF on the membrane fluidity of tumor cells.
    Stalc A; Sentjurc M; Sersa G; Novaković S
    Cancer Lett; 1992 Aug; 65(3):183-7. PubMed ID: 1325283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-interferon-induced time-dependent changes in the plasma membrane lipid bilayer of cultured cells.
    Pfeffer LM; Landsberger FR; Tamm I
    J Interferon Res; 1981; 1(4):613-20. PubMed ID: 6180094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The extracellular pH and membrane fluidity on intracellular retention of adriamycin].
    Marutaka M; Iwagaki H; Aoki H; Suguri T; Tanaka N; Orita K
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2415-9. PubMed ID: 7944485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of membrane fluidity in K562 cells exposed to the anticancer drug adriamycin.
    Marutaka M; Iwagaki H; Suguri T; Tanaka N; Orita K
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):163-70. PubMed ID: 7994561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of tumor necrosis-factor on primary human leukemia cells: ultrastructural changes.
    Munker R; Greither L; Darsow M; Ellwart JW; Mailhammer R; Wilmanns W
    Acta Haematol; 1993; 90(2):77-83. PubMed ID: 8285022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine treatment of human bone marrow activates anti-leukaemia effector cells: monitoring of purging by polymerase chain reaction and DNA analysis.
    Dickinson AM; Middleton SL; Latham J; Dunn J; Thomas L; Proctor SJ
    Leukemia; 1995 Mar; 9(3):444-9. PubMed ID: 7533866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin E supplement improves erythrocyte membrane fluidity of thalassemia: an ESR spin labeling study.
    Sutipornpalangkul W; Morales NP; Unchern S; Sanvarinda Y; Chantharaksri U; Fucharoen S
    J Med Assoc Thai; 2012 Jan; 95(1):29-36. PubMed ID: 22379738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-alpha-induced apoptosis in Daudi cells: multiparametric analysis.
    Di Pietro R; Santavenere E; Centurione L; Stuppia L; Centurione MA; Vitale M; Rana R
    Cytokine; 1997 Jul; 9(7):463-70. PubMed ID: 9237808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleoside uptake and membrane fluidity studies on N-trifluoroacetyladriamycin-14-O-hemiadipate-treated human leukemia and lymphoma cells.
    Lameh J; Chuang RY; Israel M; Chuang LF
    Cancer Res; 1989 Jun; 49(11):2905-8. PubMed ID: 2541896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Actinomyces amphiphile on the fluidity of endothelial cells: a spin label study.
    Hamada Y
    J Dent Res; 1996 Apr; 75(4):1002-7. PubMed ID: 8708128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent.
    Nathan I; Ben-Valid I; Henzel R; Masalha H; Baram SN; Dvilansky A; Parola AH
    Exp Cell Res; 1998 Mar; 239(2):442-6. PubMed ID: 9521862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible mechanism of dantrolene stabilization of cultured neuroblastoma cell plasma membranes.
    Hayashi T; Kagaya A; Motohashi N; Yamawaki S
    J Neurochem; 1994 Nov; 63(5):1849-54. PubMed ID: 7931341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of TNF-alpha/colchicine combined treatment on Burkitt lymphoma cells: molecular and ultrastructural changes.
    Di Pietro R; Robuffo I; Pucci AM; Bosco D; Santavenere E
    Cytokine; 1999 Feb; 11(2):144-50. PubMed ID: 10089136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed alteration of membrane fluidity in intact cultured B-16 melanoma cells affected by ultraviolet irradiation.
    Sakanashi T; Sugiyama M; Suematsu T; Hidaka T; Ogura R
    Biochem Int; 1986 Feb; 12(2):341-6. PubMed ID: 3008753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction.
    Li Q; Zhang Q; Wang M; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
    Clin Immunol; 2008 Jan; 126(1):67-80. PubMed ID: 17964857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of interferon-gamma and -beta on fatty acid turnover, lipid bilayer fluidity and TNF-alpha release in murine macrophage J774.2 cells.
    Darmani H; Harwood JL; Jackson SK
    Int J Exp Pathol; 1995 Oct; 76(5):331-7. PubMed ID: 7488547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spin label studies on rat liver and heart plasma membranes: effects of temperature, calcium, and lanthanum on membrane fluidity.
    Gordon LM; Sauerheber RD; Esgate JA
    J Supramol Struct; 1978; 9(3):299-326. PubMed ID: 219296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in plasma membrane fluidity of immortal rodent cells induced by anticancer drugs doxorubicin, aclarubicin and mitoxantrone.
    Jedrzejczak M; Koceva-Chyła A; Gwoździński K; Jóźwiak Z
    Cell Biol Int; 1999; 23(7):497-506. PubMed ID: 10728787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.